Not Yet RecruitingPhase 3ACTRN12609000125224

Topical use of immunosupressor,Tacrolimus, in desquamative gingivitis patients: an open trial.

Use of topical immunosupressant,Tacrolimus, in desquamative gingivitis patients: evaluation of effectiveness according to individual and disease characteristics.

Sponsor

University of Sao Paulo

Enrollment

20 participants

Start Date

Sep 1, 2008

Study Type

Interventional

Conditions

Desquamative gingivitis

Summary

The main purpose of this trial is to assess the therapeutic efficacy of tacrolimus, in topical use, to the symptomatic treatment of desquamative gingivitis.

Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

This trial tests whether a topical cream containing tacrolimus (an immune-suppressing medication) can help treat desquamative gingivitis, a painful condition where the gums become red, peeling, and sore. Anyone with this gum condition can participate, regardless of age or gender, as long as they don't have kidney or liver disease.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The patient will be shaped to get a plate of silicon on top of the model study, after will be delivered promptly to the patient with a tube of medication with Tacrolimus 0.1% gel, the patient will be

The patient will be shaped to get a plate of silicon on top of the model study, after will be delivered promptly to the patient with a tube of medication with Tacrolimus 0.1% gel, the patient will be guided in making the application through the trays that have the gel in it and take position in the mouth for 5 minutes twice a day for 90 days.

Locations(1)

Sao Paulo, Brazil

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000125224